급성 림프모구 백혈병 (Korean Wikipedia)
Analysis of information sources in references of the Wikipedia article "급성 림프모구 백혈병" in Korean language version.
refsWebsite
Global rank
Korean rank
11th place
310th place
5th place
11th place
1st place
1st place
3rd place
9th place
719th place
424th place
1,684th place
647th place
4,585th place
low place
18th place
27th place
6,846th place
7,334th place
6th place
18th place
5,619th place
9,269th place
3,097th place
1,083rd place
8,869th place
4,351st place
3,680th place
3,568th place
low place
low place
615th place
1,789th place
aacrjournals.org (Global: 8,869th place; Korean: 4,351st place)
clincancerres.aacrjournals.org
- Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R (April 2005). “Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia”. 《Clinical Cancer Research》 11 (8): 2974–80. doi:10.1158/1078-0432.CCR-04-1829. PMID 15837750.
archive.org (Global: 6th place; Korean: 18th place)
- Tubergen DG, Bleyer A, Ritchey AK (2011). 〈Acute Lymphoblastic Leukemia〉 19판. Kliegman RM, Stanton BM, Geme J, Schor NF, Behrman RE (편집). 《Nelson Textbook of Pediatrics》. Philadelphia, PA: Elsevier/Saunders. 1732–1737쪽. ISBN 978-1437707557. OCLC 706780860.
books.google.com (Global: 3rd place; Korean: 9th place)
- Ferri, Fred F. (2017). 《Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1》. Elsevier Health Sciences. 743쪽. ISBN 9780323529570.
- Marino, Bradley S.; Fine, Katie S. (2013). 《Blueprints Pediatrics》. Lippincott Williams & Wilkins. 205쪽. ISBN 9781451116045.
- Hoffbrand, Victor; Moss, Paul; Pettit, John (2006년 10월 31일). 《Essential Haematology》. Wiley. 192–196쪽. ISBN 978-1-4051-3649-5. 2015년 3월 21일에 원본 문서에서 보존된 문서. 2013년 9월 14일에 확인함.
businesswire.com (Global: 615th place; Korean: 1,789th place)
- “U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia”. 《Kite》. 2021년 10월 1일. 2021년 10월 1일에 확인함 – Business Wire 경유.
cancer.ca (Global: low place; Korean: low place)
- “Prognosis and survival for acute lymphocytic leukemia - Canadian Cance”. 《www.cancer.ca》. 2017년 12월 7일에 원본 문서에서 보존된 문서. 2017년 12월 6일에 확인함.
cancer.gov (Global: 1,684th place; Korean: 647th place)
cancer.gov
- “Childhood Acute Lymphoblastic Leukemia Treatment”. 《National Cancer Institute》. 2017년 12월 8일. 2017년 12월 20일에 확인함.
- “Adult Acute Lymphoblastic Leukemia Treatment”. 《National Cancer Institute》. 2017년 12월 6일에 확인함.
seer.cancer.gov
- “Acute Lymphocytic Leukemia – Cancer Stat Facts”. 《SEER》. 2017년 12월 20일에 확인함.
cancer.org (Global: 3,680th place; Korean: 3,568th place)
- “ACS :: How Is Acute Lymphocytic Leukemia Classified?”. 2008년 3월 23일에 원본 문서에서 보존된 문서.
doi.org (Global: 2nd place; Korean: 3rd place)
dx.doi.org
- Hunger SP, Mullighan CG (October 2015). “Acute Lymphoblastic Leukemia in Children” (영어). 《The New England Journal of Medicine》 373 (16): 1541–52. doi:10.1056/nejmra1400972. PMID 26465987. S2CID 609394.
- Inaba H, Greaves M, Mullighan CG (June 2013). “Acute lymphoblastic leukaemia”. 《Lancet》 381 (9881): 1943–55. doi:10.1016/S0140-6736(12)62187-4. PMC 3816716. PMID 23523389.
- Cordo V, Meijerink J (January 2021). “T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies”. 《Blood Cancer Discovery》 2 (1): 19–31. doi:10.1158/2643-3230.BCD-20-0093. PMC 8447273. PMID 34661151.
- Paul S, Kantarjian H, Jabbour EJ (November 2016). “Adult Acute Lymphoblastic Leukemia”. 《Mayo Clinic Proceedings》 91 (11): 1645–1666. doi:10.1016/j.mayocp.2016.09.010. PMID 27814839.
- Boer JM, den Boer ML (September 2017). “BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside”. 《European Journal of Cancer》 82: 203–218. doi:10.1016/j.ejca.2017.06.012. PMID 28709134.
- Wang, Haidong; Naghavi, Mohsen; Allen, Christine; Barber, Ryan M.; Bhutta, Zulfiqar A.; Carter, Austin; Casey, Daniel C.; Charlson, Fiona J.; Chen, Alan Zian; Coates, Matthew M.; Coggeshall, Megan; Dandona, Lalit; Dicker, Daniel J.; Erskine, Holly E.; Ferrari, Alize J.; Fitzmaurice, Christina; Foreman, Kyle; Forouzanfar, Mohammad H.; Fraser, Maya S.; Fullman, Nancy; Gething, Peter W.; Goldberg, Ellen M.; Graetz, Nicholas; Haagsma, Juanita A.; Hay, Simon I.; Huynh, Chantal; Johnson, Catherine O.; Kassebaum, Nicholas J.; Kinfu, Yohannes 외 (October 2016). “Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015”. 《Lancet》 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
- Pui, Ching-Hon; Evans, William E. (2006년 1월 12일). “Treatment of Acute Lymphoblastic Leukemia”. 《New England Journal of Medicine》 354 (2): 166–178. doi:10.1056/NEJMra052603. ISSN 0028-4793. PMID 16407512.
- Larson, Richard A. (2018년 1월 2일). “Managing CNS disease in adults with acute lymphoblastic leukemia”. 《Leukemia & Lymphoma》 59 (1): 3–13. doi:10.1080/10428194.2017.1326597. ISSN 1042-8194. PMID 28535095. S2CID 24564241.
- Vos, Theo; Allen, Christine; Arora, Megha; Barber, Ryan M.; Bhutta, Zulfiqar A.; Brown, Alexandria; Carter, Austin; Casey, Daniel C.; Charlson, Fiona J.; Chen, Alan Z.; Coggeshall, Megan; Cornaby, Leslie; Dandona, Lalit; Dicker, Daniel J.; Dilegge, Tina; Erskine, Holly E.; Ferrari, Alize J.; Fitzmaurice, Christina; Fleming, Tom; Forouzanfar, Mohammad H.; Fullman, Nancy; Gething, Peter W.; Goldberg, Ellen M.; Graetz, Nicholas; Haagsma, Juanita A.; Hay, Simon I.; Johnson, Catherine O.; Kassebaum, Nicholas J.; Kawashima, Toana 외 (October 2016). “Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015”. 《Lancet》 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
- Brown P (2013년 12월 6일). “Treatment of infant leukemias: challenge and promise”. 《Hematology. American Society of Hematology. Education Program》 2013 (1): 596–600. doi:10.1182/asheducation-2013.1.596. PMC 4729208. PMID 24319237.
- Clarke RT, Van den Bruel A, Bankhead C, Mitchell CD, Phillips B, Thompson MJ (October 2016). “Clinical presentation of childhood leukaemia: a systematic review and meta-analysis”. 《Archives of Disease in Childhood》 101 (10): 894–901. doi:10.1136/archdischild-2016-311251. PMID 27647842.
- Cortes J (February 2001). “Central nervous system involvement in adult acute lymphocytic leukemia”. 《Hematology/Oncology Clinics of North America》 15 (1): 145–62. doi:10.1016/s0889-8588(05)70203-3. PMID 11253605.
- Bleyer WA (August 1988). “Central nervous system leukemia”. 《Pediatric Clinics of North America》 35 (4): 789–814. doi:10.1016/s0031-3955(16)36510-5. PMID 3047654.
- Ingram LC, Fairclough DL, Furman WL, Sandlund JT, Kun LE, Rivera GK, Pui CH (May 1991). “Cranial nerve palsy in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma”. 《Cancer》 67 (9): 2262–8. doi:10.1002/1097-0142(19910501)67:9<2262::aid-cncr2820670909>3.0.co;2-u. PMID 2013032.
- Terwilliger T, Abdul-Hay M (June 2017). “Acute lymphoblastic leukemia: a comprehensive review and 2017 update”. 《Blood Cancer Journal》 7 (6): e577. doi:10.1038/bcj.2017.53. PMC 5520400. PMID 28665419.
- Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M 외 (November 2013). “The MLL recombinome of acute leukemias in 2013”. 《Leukemia》 27 (11): 2165–76. doi:10.1038/leu.2013.135. PMC 3826032. PMID 23628958.
- Benedikt A, Baltruschat S, Scholz B, Bursen A, Arrey TN, Meyer B 외 (January 2011). “The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures”. 《Leukemia》 25 (1): 135–44. doi:10.1038/leu.2010.249. PMID 21030982.
- Smith MA, Rubinstein L, Anderson JR, Arthur D, Catalano PJ, Freidlin B 외 (February 1999). “Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins”. 《Journal of Clinical Oncology》 17 (2): 569–77. doi:10.1200/JCO.1999.17.2.569. PMID 10080601.
- Greaves M (August 2018). “A causal mechanism for childhood acute lymphoblastic leukaemia”. 《Nature Reviews. Cancer》 18 (8): 471–484. doi:10.1038/s41568-018-0015-6. PMC 6986894. PMID 29784935.
- Hunger SP, Mullighan CG (October 2015). “Acute Lymphoblastic Leukemia in Children” (영어). 《The New England Journal of Medicine》 373 (16): 1541–52. doi:10.1056/nejmra1400972. PMID 26465987. S2CID 609394.
- Inaba H, Greaves M, Mullighan CG (June 2013). “Acute lymphoblastic leukaemia”. 《Lancet》 381 (9881): 1943–55. doi:10.1016/S0140-6736(12)62187-4. PMC 3816716. PMID 23523389.
- Bhojwani D, Pei D, Sandlund JT, Jeha S, Ribeiro RC, Rubnitz JE 외 (February 2012). “ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy”. 《Leukemia》 26 (2): 265–70. doi:10.1038/leu.2011.227. PMC 3345278. PMID 21869842.
- Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R (April 2005). “Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia”. 《Clinical Cancer Research》 11 (8): 2974–80. doi:10.1158/1078-0432.CCR-04-1829. PMID 15837750.
- Pakakasama S, Kajanachumpol S, Kanjanapongkul S, Sirachainan N, Meekaewkunchorn A, Ningsanond V, Hongeng S (August 2008). “Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia”. 《International Journal of Laboratory Hematology》 30 (4): 286–91. doi:10.1111/j.1751-553X.2007.00954.x. PMID 18665825.
- McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C (September 1999). “Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia”. 《Proceedings of the National Academy of Sciences of the United States of America》 96 (20): 11464–9. Bibcode:1999PNAS...9611464M. doi:10.1073/pnas.96.20.11464. PMC 18056. PMID 10500199.
- Rudolph C, Hegazy AN, von Neuhoff N, Steinemann D, Schröck E, Stripecke R 외 (August 2005). “Cytogenetic characterization of a BCR-ABL transduced mouse cell line”. 《Cancer Genetics and Cytogenetics》 161 (1): 51–6. doi:10.1016/j.cancergencyto.2004.12.021. PMID 16080957.
- Caslini C, Serna A, Rossi V, Introna M, Biondi A (June 2004). “Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein”. 《Leukemia》 18 (6): 1064–71. doi:10.1038/sj.leu.2403321. PMID 14990976.
- Martín-Subero JI, Odero MD, Hernandez R, Cigudosa JC, Agirre X, Saez B 외 (August 2005). “Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas”. 《Genes, Chromosomes & Cancer》 43 (4): 414–23. doi:10.1002/gcc.20187. PMID 15852472. S2CID 2025900.
- Zalcberg IQ, Silva ML, Abdelhay E, Tabak DG, Ornellas MH, Simões FV 외 (October 1995). “Translocation 11;14 in three children with acute lymphoblastic leukemia of T-cell origin”. 《Cancer Genetics and Cytogenetics》 84 (1): 32–8. doi:10.1016/0165-4608(95)00062-3. PMID 7497440.
- Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (August 1976). “Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group”. 《British Journal of Haematology》 33 (4): 451–8. doi:10.1111/j.1365-2141.1976.tb03563.x. PMID 188440. S2CID 9985915.
- Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM 외 (May 2016). “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia”. 《Blood》 127 (20): 2391–405. doi:10.1182/blood-2016-03-643544. PMID 27069254. S2CID 18338178.
- Jabbour E, Thomas D, Cortes J, Kantarjian HM, O'Brien S (May 2010). “Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies”. 《Cancer》 116 (10): 2290–300. doi:10.1002/cncr.25008. PMID 20209620. S2CID 13634096.
- Yanada M (June 2015). “Time to tune the treatment of Ph+ ALL”. 《Blood》 125 (24): 3674–5. doi:10.1182/blood-2015-04-641704. PMID 26069331.
- Lambrou GI, Papadimitriou L, Chrousos GP, Vlahopoulos SA (April 2012). “Glucocorticoid and proteasome inhibitor impact on the leukemic lymphoblast: multiple, diverse signals converging on a few key downstream regulators”. 《Molecular and Cellular Endocrinology》 351 (2): 142–51. doi:10.1016/j.mce.2012.01.003. PMID 22273806. S2CID 28749125.
- Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR 외 (April 2013). “Chimeric antigen receptor-modified T cells for acute lymphoid leukemia”. 《The New England Journal of Medicine》 368 (16): 1509–1518. doi:10.1056/NEJMoa1215134. PMC 4058440. PMID 23527958.
- Barrett DM, Singh N, Porter DL, Grupp SA, June CH (2014). “Chimeric antigen receptor therapy for cancer”. 《Annual Review of Medicine》 65: 333–47. doi:10.1146/annurev-med-060512-150254. PMC 4120077. PMID 24274181.
- Alonso-Camino V, Sánchez-Martín D, Compte M, Nuñez-Prado N, Diaz RM, Vile R, Alvarez-Vallina L (May 2013). “CARbodies: Human Antibodies Against Cell Surface Tumor Antigens Selected From Repertoires Displayed on T Cell Chimeric Antigen Receptors”. 《Molecular Therapy: Nucleic Acids》 2 (5): e93. doi:10.1038/mtna.2013.19. PMC 4817937. PMID 23695536.
- Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D (December 1998). “Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery”. 《Journal of Virology》 72 (12): 9873–80. doi:10.1128/JVI.72.12.9873-9880.1998. PMC 110499. PMID 9811723.
- Ledford H (July 2017). “Engineered cell therapy for cancer gets thumbs up from FDA advisers”. 《Nature》 547 (7663): 270. Bibcode:2017Natur.547..270L. doi:10.1038/nature.2017.22304. PMID 28726836.
- Kantarjian H, Stein A, Gökbuget N, Fielding AK, Schuh AC, Ribera JM 외 (March 2017). “Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia” (영어). 《The New England Journal of Medicine》 376 (9): 836–847. doi:10.1056/nejmoa1609783. PMC 5881572. PMID 28249141.
- Estcourt L, Stanworth S, Doree C, Hopewell S, Murphy MF, Tinmouth A, Heddle N (May 2012). Cochrane Haematological Malignancies Group (편집). “Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation”. 《The Cochrane Database of Systematic Reviews》 (5): CD004269. doi:10.1002/14651858.CD004269.pub3. PMID 22592695.
- Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF (November 2015). Cochrane Haematological Malignancies Group (편집). “Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation”. 《The Cochrane Database of Systematic Reviews》 2015 (11): CD010983. doi:10.1002/14651858.CD010983.pub2. PMC 4717525. PMID 26576687.
- Fisher SA, Cutler A, Doree C, Brunskill SJ, Stanworth SJ, Navarrete C, Girdlestone J (January 2019). Cochrane Haematological Malignancies Group (편집). “Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition”. 《The Cochrane Database of Systematic Reviews》 1 (1): CD009768. doi:10.1002/14651858.CD009768.pub2. PMC 6353308. PMID 30697701.
- Knips L, Bergenthal N, Streckmann F, Monsef I, Elter T, Skoetz N (January 2019). Cochrane Haematological Malignancies Group (편집). “Aerobic physical exercise for adult patients with haematological malignancies”. 《The Cochrane Database of Systematic Reviews》 1 (1): CD009075. doi:10.1002/14651858.CD009075.pub3. PMC 6354325. PMID 30702150.
- Hutter JJ (June 2010). “Childhood leukemia”. 《Pediatrics in Review》 31 (6): 234–41. doi:10.1542/pir.31-6-234. PMID 20516235.
- Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M 외 (April 2007). “Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial”. 《Blood》 109 (8): 3189–97. doi:10.1182/blood-2006-10-051912. PMID 17170120. S2CID 1038016.
- Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST 외 (February 2009). “A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study”. 《The Lancet. Oncology》 10 (2): 125–34. doi:10.1016/S1470-2045(08)70339-5. PMC 2707020. PMID 19138562.
- Guo LM, Xi JS, Ma Y, Shao L, Nie CL, Wang GJ (January 2014). “ARID5B gene rs10821936 polymorphism is associated with childhood acute lymphoblastic leukemia: a meta-analysis based on 39,116 subjects”. 《Tumour Biology》 35 (1): 709–13. doi:10.1007/s13277-013-1097-0. PMID 23975371. S2CID 12601034.
- Shapira T, Pereg D, Lishner M (September 2008). “How I treat acute and chronic leukemia in pregnancy”. 《Blood Reviews》 22 (5): 247–59. doi:10.1016/j.blre.2008.03.006. PMID 18472198.
doi.org
- Pui, Ching-Hon; Evans, William E. (2006년 1월 12일). “Treatment of Acute Lymphoblastic Leukemia”. 《New England Journal of Medicine》 354 (2): 166–178. doi:10.1056/NEJMra052603. ISSN 0028-4793. PMID 16407512.
- Larson, Richard A. (2018년 1월 2일). “Managing CNS disease in adults with acute lymphoblastic leukemia”. 《Leukemia & Lymphoma》 59 (1): 3–13. doi:10.1080/10428194.2017.1326597. ISSN 1042-8194. PMID 28535095. S2CID 24564241.
fda.gov (Global: 447th place; Korean: 433rd place)
- Office of the Commissioner. “Press Announcements—FDA approval brings first gene therapy to the United States”. 《www.fda.gov》. 2017년 9월 3일에 원본 문서에서 보존된 문서. 2017년 9월 12일에 확인함.
- “FDA approves brexucabtagene autoleucel for relapsed or refractory B-cell precursor acute lymphoblastic leukemia”. 《U.S. Food and Drug Administration (FDA)》. 2021년 10월 1일. 2021년 10월 2일에 확인함.
이 문서는 퍼블릭 도메인 출처의 본문을 포함합니다. - “FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL”. 《U.S. Food and Drug Administration (FDA)》. 2020년 7월 24일. 2020년 7월 24일에 확인함. 이 문서는 퍼블릭 도메인 출처의 본문을 포함합니다.
harvard.edu (Global: 18th place; Korean: 27th place)
adsabs.harvard.edu
- McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C (September 1999). “Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia”. 《Proceedings of the National Academy of Sciences of the United States of America》 96 (20): 11464–9. Bibcode:1999PNAS...9611464M. doi:10.1073/pnas.96.20.11464. PMC 18056. PMID 10500199.
- Ledford H (July 2017). “Engineered cell therapy for cancer gets thumbs up from FDA advisers”. 《Nature》 547 (7663): 270. Bibcode:2017Natur.547..270L. doi:10.1038/nature.2017.22304. PMID 28726836.
lecturio.com (Global: 5,619th place; Korean: 9,269th place)
- “Acute Lymphoblastic Leukemia”. 《The Lecturio Medical Concept Library》. 2021년 6월 27일에 확인함.
medscape.com (Global: 719th place; Korean: 424th place)
emedicine.medscape.com
- Acute Lymphoblastic Leukemia - eMedicine
- Acute Lymphoblastic Leukemia - eMedicine
- Seiter K, Harris JE. Acute Lymphoblastic Leukemia Treatment Protocols. emedicine; Medscape. “Acute Lymphoblastic Leukemia Treatment Protocols: Treatment Protocols”. 2015년 9월 1일에 원본 문서에서 보존된 문서. 2015년 8월 16일에 확인함.
merckmanuals.com (Global: 3,097th place; Korean: 1,083rd place)
- Rytting, ME 편집 (November 2013). “Acute Leukemia”. 《Merck Manual Professional》. Merck Sharp & Dohme Corp. 15 July 2014에 원본 문서에서 보존된 문서. 17 April 2014에 확인함.
mhmedical.com (Global: 6,846th place; Korean: 7,334th place)
accessmedicine.mhmedical.com
- Baljevic M, Jabbour E, O'Brien S, Kantarjian HM (2016). 〈Acute Lymphoblastic Leukemia〉 3판. Kantarjian HM, Wolff RA (편집). 《The MD Anderson Manual of Medical Oncology》. New York: McGraw-Hill Education. 2017년 11월 22일에 확인함.
mountsinai.org (Global: low place; Korean: low place)
- “Acute lymphoblastic leukemia (ALL) Information – Mount Sinai – New York”. 《Mount Sinai Health System》. 2016년 8월 3일에 원본 문서에서 보존된 문서. 2017년 11월 18일에 확인함.
nih.gov (Global: 4th place; Korean: 4th place)
ncbi.nlm.nih.gov
- Hunger SP, Mullighan CG (October 2015). “Acute Lymphoblastic Leukemia in Children” (영어). 《The New England Journal of Medicine》 373 (16): 1541–52. doi:10.1056/nejmra1400972. PMID 26465987. S2CID 609394.
- Inaba H, Greaves M, Mullighan CG (June 2013). “Acute lymphoblastic leukaemia”. 《Lancet》 381 (9881): 1943–55. doi:10.1016/S0140-6736(12)62187-4. PMC 3816716. PMID 23523389.
- Cordo V, Meijerink J (January 2021). “T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies”. 《Blood Cancer Discovery》 2 (1): 19–31. doi:10.1158/2643-3230.BCD-20-0093. PMC 8447273. PMID 34661151.
- Paul S, Kantarjian H, Jabbour EJ (November 2016). “Adult Acute Lymphoblastic Leukemia”. 《Mayo Clinic Proceedings》 91 (11): 1645–1666. doi:10.1016/j.mayocp.2016.09.010. PMID 27814839.
- Boer JM, den Boer ML (September 2017). “BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside”. 《European Journal of Cancer》 82: 203–218. doi:10.1016/j.ejca.2017.06.012. PMID 28709134.
- Wang, Haidong; Naghavi, Mohsen; Allen, Christine; Barber, Ryan M.; Bhutta, Zulfiqar A.; Carter, Austin; Casey, Daniel C.; Charlson, Fiona J.; Chen, Alan Zian; Coates, Matthew M.; Coggeshall, Megan; Dandona, Lalit; Dicker, Daniel J.; Erskine, Holly E.; Ferrari, Alize J.; Fitzmaurice, Christina; Foreman, Kyle; Forouzanfar, Mohammad H.; Fraser, Maya S.; Fullman, Nancy; Gething, Peter W.; Goldberg, Ellen M.; Graetz, Nicholas; Haagsma, Juanita A.; Hay, Simon I.; Huynh, Chantal; Johnson, Catherine O.; Kassebaum, Nicholas J.; Kinfu, Yohannes 외 (October 2016). “Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015”. 《Lancet》 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
- Pui, Ching-Hon; Evans, William E. (2006년 1월 12일). “Treatment of Acute Lymphoblastic Leukemia”. 《New England Journal of Medicine》 354 (2): 166–178. doi:10.1056/NEJMra052603. ISSN 0028-4793. PMID 16407512.
- Larson, Richard A. (2018년 1월 2일). “Managing CNS disease in adults with acute lymphoblastic leukemia”. 《Leukemia & Lymphoma》 59 (1): 3–13. doi:10.1080/10428194.2017.1326597. ISSN 1042-8194. PMID 28535095. S2CID 24564241.
- Vos, Theo; Allen, Christine; Arora, Megha; Barber, Ryan M.; Bhutta, Zulfiqar A.; Brown, Alexandria; Carter, Austin; Casey, Daniel C.; Charlson, Fiona J.; Chen, Alan Z.; Coggeshall, Megan; Cornaby, Leslie; Dandona, Lalit; Dicker, Daniel J.; Dilegge, Tina; Erskine, Holly E.; Ferrari, Alize J.; Fitzmaurice, Christina; Fleming, Tom; Forouzanfar, Mohammad H.; Fullman, Nancy; Gething, Peter W.; Goldberg, Ellen M.; Graetz, Nicholas; Haagsma, Juanita A.; Hay, Simon I.; Johnson, Catherine O.; Kassebaum, Nicholas J.; Kawashima, Toana 외 (October 2016). “Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015”. 《Lancet》 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
- Brown P (2013년 12월 6일). “Treatment of infant leukemias: challenge and promise”. 《Hematology. American Society of Hematology. Education Program》 2013 (1): 596–600. doi:10.1182/asheducation-2013.1.596. PMC 4729208. PMID 24319237.
- Clarke RT, Van den Bruel A, Bankhead C, Mitchell CD, Phillips B, Thompson MJ (October 2016). “Clinical presentation of childhood leukaemia: a systematic review and meta-analysis”. 《Archives of Disease in Childhood》 101 (10): 894–901. doi:10.1136/archdischild-2016-311251. PMID 27647842.
- Cortes J (February 2001). “Central nervous system involvement in adult acute lymphocytic leukemia”. 《Hematology/Oncology Clinics of North America》 15 (1): 145–62. doi:10.1016/s0889-8588(05)70203-3. PMID 11253605.
- Bleyer WA (August 1988). “Central nervous system leukemia”. 《Pediatric Clinics of North America》 35 (4): 789–814. doi:10.1016/s0031-3955(16)36510-5. PMID 3047654.
- Ingram LC, Fairclough DL, Furman WL, Sandlund JT, Kun LE, Rivera GK, Pui CH (May 1991). “Cranial nerve palsy in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma”. 《Cancer》 67 (9): 2262–8. doi:10.1002/1097-0142(19910501)67:9<2262::aid-cncr2820670909>3.0.co;2-u. PMID 2013032.
- Terwilliger T, Abdul-Hay M (June 2017). “Acute lymphoblastic leukemia: a comprehensive review and 2017 update”. 《Blood Cancer Journal》 7 (6): e577. doi:10.1038/bcj.2017.53. PMC 5520400. PMID 28665419.
- Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M 외 (November 2013). “The MLL recombinome of acute leukemias in 2013”. 《Leukemia》 27 (11): 2165–76. doi:10.1038/leu.2013.135. PMC 3826032. PMID 23628958.
- Benedikt A, Baltruschat S, Scholz B, Bursen A, Arrey TN, Meyer B 외 (January 2011). “The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures”. 《Leukemia》 25 (1): 135–44. doi:10.1038/leu.2010.249. PMID 21030982.
- Smith MA, Rubinstein L, Anderson JR, Arthur D, Catalano PJ, Freidlin B 외 (February 1999). “Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins”. 《Journal of Clinical Oncology》 17 (2): 569–77. doi:10.1200/JCO.1999.17.2.569. PMID 10080601.
- Greaves M (August 2018). “A causal mechanism for childhood acute lymphoblastic leukaemia”. 《Nature Reviews. Cancer》 18 (8): 471–484. doi:10.1038/s41568-018-0015-6. PMC 6986894. PMID 29784935.
- Hunger SP, Mullighan CG (October 2015). “Acute Lymphoblastic Leukemia in Children” (영어). 《The New England Journal of Medicine》 373 (16): 1541–52. doi:10.1056/nejmra1400972. PMID 26465987. S2CID 609394.
- Inaba H, Greaves M, Mullighan CG (June 2013). “Acute lymphoblastic leukaemia”. 《Lancet》 381 (9881): 1943–55. doi:10.1016/S0140-6736(12)62187-4. PMC 3816716. PMID 23523389.
- Bhojwani D, Pei D, Sandlund JT, Jeha S, Ribeiro RC, Rubnitz JE 외 (February 2012). “ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy”. 《Leukemia》 26 (2): 265–70. doi:10.1038/leu.2011.227. PMC 3345278. PMID 21869842.
- Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R (April 2005). “Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia”. 《Clinical Cancer Research》 11 (8): 2974–80. doi:10.1158/1078-0432.CCR-04-1829. PMID 15837750.
- Pakakasama S, Kajanachumpol S, Kanjanapongkul S, Sirachainan N, Meekaewkunchorn A, Ningsanond V, Hongeng S (August 2008). “Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia”. 《International Journal of Laboratory Hematology》 30 (4): 286–91. doi:10.1111/j.1751-553X.2007.00954.x. PMID 18665825.
- McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C (September 1999). “Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia”. 《Proceedings of the National Academy of Sciences of the United States of America》 96 (20): 11464–9. Bibcode:1999PNAS...9611464M. doi:10.1073/pnas.96.20.11464. PMC 18056. PMID 10500199.
- Rudolph C, Hegazy AN, von Neuhoff N, Steinemann D, Schröck E, Stripecke R 외 (August 2005). “Cytogenetic characterization of a BCR-ABL transduced mouse cell line”. 《Cancer Genetics and Cytogenetics》 161 (1): 51–6. doi:10.1016/j.cancergencyto.2004.12.021. PMID 16080957.
- Caslini C, Serna A, Rossi V, Introna M, Biondi A (June 2004). “Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein”. 《Leukemia》 18 (6): 1064–71. doi:10.1038/sj.leu.2403321. PMID 14990976.
- Martín-Subero JI, Odero MD, Hernandez R, Cigudosa JC, Agirre X, Saez B 외 (August 2005). “Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas”. 《Genes, Chromosomes & Cancer》 43 (4): 414–23. doi:10.1002/gcc.20187. PMID 15852472. S2CID 2025900.
- Zalcberg IQ, Silva ML, Abdelhay E, Tabak DG, Ornellas MH, Simões FV 외 (October 1995). “Translocation 11;14 in three children with acute lymphoblastic leukemia of T-cell origin”. 《Cancer Genetics and Cytogenetics》 84 (1): 32–8. doi:10.1016/0165-4608(95)00062-3. PMID 7497440.
- Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (August 1976). “Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group”. 《British Journal of Haematology》 33 (4): 451–8. doi:10.1111/j.1365-2141.1976.tb03563.x. PMID 188440. S2CID 9985915.
- Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM 외 (May 2016). “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia”. 《Blood》 127 (20): 2391–405. doi:10.1182/blood-2016-03-643544. PMID 27069254. S2CID 18338178.
- Jabbour E, Thomas D, Cortes J, Kantarjian HM, O'Brien S (May 2010). “Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies”. 《Cancer》 116 (10): 2290–300. doi:10.1002/cncr.25008. PMID 20209620. S2CID 13634096.
- Yanada M (June 2015). “Time to tune the treatment of Ph+ ALL”. 《Blood》 125 (24): 3674–5. doi:10.1182/blood-2015-04-641704. PMID 26069331.
- Lambrou GI, Papadimitriou L, Chrousos GP, Vlahopoulos SA (April 2012). “Glucocorticoid and proteasome inhibitor impact on the leukemic lymphoblast: multiple, diverse signals converging on a few key downstream regulators”. 《Molecular and Cellular Endocrinology》 351 (2): 142–51. doi:10.1016/j.mce.2012.01.003. PMID 22273806. S2CID 28749125.
- Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR 외 (April 2013). “Chimeric antigen receptor-modified T cells for acute lymphoid leukemia”. 《The New England Journal of Medicine》 368 (16): 1509–1518. doi:10.1056/NEJMoa1215134. PMC 4058440. PMID 23527958.
- Barrett DM, Singh N, Porter DL, Grupp SA, June CH (2014). “Chimeric antigen receptor therapy for cancer”. 《Annual Review of Medicine》 65: 333–47. doi:10.1146/annurev-med-060512-150254. PMC 4120077. PMID 24274181.
- Alonso-Camino V, Sánchez-Martín D, Compte M, Nuñez-Prado N, Diaz RM, Vile R, Alvarez-Vallina L (May 2013). “CARbodies: Human Antibodies Against Cell Surface Tumor Antigens Selected From Repertoires Displayed on T Cell Chimeric Antigen Receptors”. 《Molecular Therapy: Nucleic Acids》 2 (5): e93. doi:10.1038/mtna.2013.19. PMC 4817937. PMID 23695536.
- Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D (December 1998). “Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery”. 《Journal of Virology》 72 (12): 9873–80. doi:10.1128/JVI.72.12.9873-9880.1998. PMC 110499. PMID 9811723.
- Ledford H (July 2017). “Engineered cell therapy for cancer gets thumbs up from FDA advisers”. 《Nature》 547 (7663): 270. Bibcode:2017Natur.547..270L. doi:10.1038/nature.2017.22304. PMID 28726836.
- Kantarjian H, Stein A, Gökbuget N, Fielding AK, Schuh AC, Ribera JM 외 (March 2017). “Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia” (영어). 《The New England Journal of Medicine》 376 (9): 836–847. doi:10.1056/nejmoa1609783. PMC 5881572. PMID 28249141.
- Estcourt L, Stanworth S, Doree C, Hopewell S, Murphy MF, Tinmouth A, Heddle N (May 2012). Cochrane Haematological Malignancies Group (편집). “Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation”. 《The Cochrane Database of Systematic Reviews》 (5): CD004269. doi:10.1002/14651858.CD004269.pub3. PMID 22592695.
- Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF (November 2015). Cochrane Haematological Malignancies Group (편집). “Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation”. 《The Cochrane Database of Systematic Reviews》 2015 (11): CD010983. doi:10.1002/14651858.CD010983.pub2. PMC 4717525. PMID 26576687.
- Fisher SA, Cutler A, Doree C, Brunskill SJ, Stanworth SJ, Navarrete C, Girdlestone J (January 2019). Cochrane Haematological Malignancies Group (편집). “Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition”. 《The Cochrane Database of Systematic Reviews》 1 (1): CD009768. doi:10.1002/14651858.CD009768.pub2. PMC 6353308. PMID 30697701.
- Knips L, Bergenthal N, Streckmann F, Monsef I, Elter T, Skoetz N (January 2019). Cochrane Haematological Malignancies Group (편집). “Aerobic physical exercise for adult patients with haematological malignancies”. 《The Cochrane Database of Systematic Reviews》 1 (1): CD009075. doi:10.1002/14651858.CD009075.pub3. PMC 6354325. PMID 30702150.
- Hutter JJ (June 2010). “Childhood leukemia”. 《Pediatrics in Review》 31 (6): 234–41. doi:10.1542/pir.31-6-234. PMID 20516235.
- Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M 외 (April 2007). “Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial”. 《Blood》 109 (8): 3189–97. doi:10.1182/blood-2006-10-051912. PMID 17170120. S2CID 1038016.
- Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST 외 (February 2009). “A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study”. 《The Lancet. Oncology》 10 (2): 125–34. doi:10.1016/S1470-2045(08)70339-5. PMC 2707020. PMID 19138562.
- Guo LM, Xi JS, Ma Y, Shao L, Nie CL, Wang GJ (January 2014). “ARID5B gene rs10821936 polymorphism is associated with childhood acute lymphoblastic leukemia: a meta-analysis based on 39,116 subjects”. 《Tumour Biology》 35 (1): 709–13. doi:10.1007/s13277-013-1097-0. PMID 23975371. S2CID 12601034.
- Urayama KY, Manabe A (October 2014). “Genomic evaluations of childhood acute lymphoblastic leukemia susceptibility across race/ethnicities”. 《[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology》 55 (10): 2242–8. PMID 25297793.
- Shapira T, Pereg D, Lishner M (September 2008). “How I treat acute and chronic leukemia in pregnancy”. 《Blood Reviews》 22 (5): 247–59. doi:10.1016/j.blre.2008.03.006. PMID 18472198.
semanticscholar.org (Global: 11th place; Korean: 310th place)
api.semanticscholar.org
- Hunger SP, Mullighan CG (October 2015). “Acute Lymphoblastic Leukemia in Children” (영어). 《The New England Journal of Medicine》 373 (16): 1541–52. doi:10.1056/nejmra1400972. PMID 26465987. S2CID 609394.
- Larson, Richard A. (2018년 1월 2일). “Managing CNS disease in adults with acute lymphoblastic leukemia”. 《Leukemia & Lymphoma》 59 (1): 3–13. doi:10.1080/10428194.2017.1326597. ISSN 1042-8194. PMID 28535095. S2CID 24564241.
- Hunger SP, Mullighan CG (October 2015). “Acute Lymphoblastic Leukemia in Children” (영어). 《The New England Journal of Medicine》 373 (16): 1541–52. doi:10.1056/nejmra1400972. PMID 26465987. S2CID 609394.
- Martín-Subero JI, Odero MD, Hernandez R, Cigudosa JC, Agirre X, Saez B 외 (August 2005). “Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas”. 《Genes, Chromosomes & Cancer》 43 (4): 414–23. doi:10.1002/gcc.20187. PMID 15852472. S2CID 2025900.
- Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (August 1976). “Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group”. 《British Journal of Haematology》 33 (4): 451–8. doi:10.1111/j.1365-2141.1976.tb03563.x. PMID 188440. S2CID 9985915.
- Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM 외 (May 2016). “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia”. 《Blood》 127 (20): 2391–405. doi:10.1182/blood-2016-03-643544. PMID 27069254. S2CID 18338178.
- Jabbour E, Thomas D, Cortes J, Kantarjian HM, O'Brien S (May 2010). “Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies”. 《Cancer》 116 (10): 2290–300. doi:10.1002/cncr.25008. PMID 20209620. S2CID 13634096.
- Lambrou GI, Papadimitriou L, Chrousos GP, Vlahopoulos SA (April 2012). “Glucocorticoid and proteasome inhibitor impact on the leukemic lymphoblast: multiple, diverse signals converging on a few key downstream regulators”. 《Molecular and Cellular Endocrinology》 351 (2): 142–51. doi:10.1016/j.mce.2012.01.003. PMID 22273806. S2CID 28749125.
- Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M 외 (April 2007). “Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial”. 《Blood》 109 (8): 3189–97. doi:10.1182/blood-2006-10-051912. PMID 17170120. S2CID 1038016.
- Guo LM, Xi JS, Ma Y, Shao L, Nie CL, Wang GJ (January 2014). “ARID5B gene rs10821936 polymorphism is associated with childhood acute lymphoblastic leukemia: a meta-analysis based on 39,116 subjects”. 《Tumour Biology》 35 (1): 709–13. doi:10.1007/s13277-013-1097-0. PMID 23975371. S2CID 12601034.
unal.edu.co (Global: 4,585th place; Korean: low place)
repositorio.unal.edu.co
- Hunger SP, Mullighan CG (October 2015). “Acute Lymphoblastic Leukemia in Children” (영어). 《The New England Journal of Medicine》 373 (16): 1541–52. doi:10.1056/nejmra1400972. PMID 26465987. S2CID 609394.
- Hunger SP, Mullighan CG (October 2015). “Acute Lymphoblastic Leukemia in Children” (영어). 《The New England Journal of Medicine》 373 (16): 1541–52. doi:10.1056/nejmra1400972. PMID 26465987. S2CID 609394.
web.archive.org (Global: 1st place; Korean: 1st place)
- Rytting, ME 편집 (November 2013). “Acute Leukemia”. 《Merck Manual Professional》. Merck Sharp & Dohme Corp. 15 July 2014에 원본 문서에서 보존된 문서. 17 April 2014에 확인함.
- “ACS :: How Is Acute Lymphocytic Leukemia Classified?”. 2008년 3월 23일에 원본 문서에서 보존된 문서.
- “Acute lymphoblastic leukemia (ALL) Information – Mount Sinai – New York”. 《Mount Sinai Health System》. 2016년 8월 3일에 원본 문서에서 보존된 문서. 2017년 11월 18일에 확인함.
- Hoffbrand, Victor; Moss, Paul; Pettit, John (2006년 10월 31일). 《Essential Haematology》. Wiley. 192–196쪽. ISBN 978-1-4051-3649-5. 2015년 3월 21일에 원본 문서에서 보존된 문서. 2013년 9월 14일에 확인함.
- Seiter K, Harris JE. Acute Lymphoblastic Leukemia Treatment Protocols. emedicine; Medscape. “Acute Lymphoblastic Leukemia Treatment Protocols: Treatment Protocols”. 2015년 9월 1일에 원본 문서에서 보존된 문서. 2015년 8월 16일에 확인함.
- Office of the Commissioner. “Press Announcements—FDA approval brings first gene therapy to the United States”. 《www.fda.gov》. 2017년 9월 3일에 원본 문서에서 보존된 문서. 2017년 9월 12일에 확인함.
- “Prognosis and survival for acute lymphocytic leukemia - Canadian Cance”. 《www.cancer.ca》. 2017년 12월 7일에 원본 문서에서 보존된 문서. 2017년 12월 6일에 확인함.
worldcat.org (Global: 5th place; Korean: 11th place)
- 《Childhood acute lymphoblastic leukemia》. Vora, Ajay (editor). Cham, Switzerland: Springer International Publishing. 2017. 1–44, 61–86쪽. ISBN 9783319397078. OCLC 984342596.
- Pui, Ching-Hon; Evans, William E. (2006년 1월 12일). “Treatment of Acute Lymphoblastic Leukemia”. 《New England Journal of Medicine》 354 (2): 166–178. doi:10.1056/NEJMra052603. ISSN 0028-4793. PMID 16407512.
- Larson, Richard A. (2018년 1월 2일). “Managing CNS disease in adults with acute lymphoblastic leukemia”. 《Leukemia & Lymphoma》 59 (1): 3–13. doi:10.1080/10428194.2017.1326597. ISSN 1042-8194. PMID 28535095. S2CID 24564241.
- Tubergen DG, Bleyer A, Ritchey AK (2011). 〈Acute Lymphoblastic Leukemia〉 19판. Kliegman RM, Stanton BM, Geme J, Schor NF, Behrman RE (편집). 《Nelson Textbook of Pediatrics》. Philadelphia, PA: Elsevier/Saunders. 1732–1737쪽. ISBN 978-1437707557. OCLC 706780860.
- Hoffbrand AV, Moss PA (2015년 10월 6일). 《Hoffbrand's essential haematology》 Seven판. Chichester, West Sussex. ISBN 9781118408636. OCLC 910009732.
- Hoffbrand AV, Moss PA (2015년 10월 26일). 《Hoffbrand's essential haematology》 Seven판. Chichester, West Sussex. ISBN 9781118408674. OCLC 909538759.
- Hoffbrand AV, Moss PA (2015년 10월 26일). 《Hoffbrand's essential haematology》 Seven판. Chichester, West Sussex. 194쪽. ISBN 9781118408674. OCLC 909538759.